NS

Nandanavanam Seshagiri Rao

Active Director Director DIN 09154998
DIN 09154998 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Nandanavanam Seshagiri Rao

Data last updated:

Nandanavanam Seshagiri Rao is a Director at Newtra Ceuticals And Biocare Private Limited (since 2021). The company operates in Chemicals.

DIN 09154998
Primary Designation Director
Industry Chemicals
First Appointment 22 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Apr 20212021Active

Board colleagues of Nandanavanam Seshagiri Rao

NameDINCompanyDesignation
Shabeeb Rabha09154997Newtra Ceuticals And Biocare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Newtra Ceuticals And Biocare Private Limited
Premium access

Shareholding and investment profile for Nandanavanam Seshagiri Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandanavanam Seshagiri Rao

Nandanavanam Seshagiri Rao currently holds 1 directorship: Newtra Ceuticals And Biocare Private Limited (Director, since 22 Apr 2021).

Nandanavanam Seshagiri Rao was first appointed on 22 Apr 2021 as Director at Newtra Ceuticals And Biocare Private Limited.

The current boards of Nandanavanam Seshagiri Rao's companies include Shabeeb Rabha (Newtra Ceuticals And Biocare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available